|
1
|
The role of Epstein-Barr virus in acute and chronic hepatitis.
|
J Hepatol
|
2006
|
1.69
|
|
2
|
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
|
Am J Gastroenterol
|
2009
|
0.97
|
|
3
|
Mixed hepatoblastoma in an adult.
|
Arch Pathol Lab Med
|
2005
|
0.88
|
|
4
|
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
|
Cancer Lett
|
2006
|
0.87
|
|
5
|
Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors.
|
Endocr Relat Cancer
|
2012
|
0.86
|
|
6
|
Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma.
|
Int J Cancer
|
2008
|
0.85
|
|
7
|
Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?
|
Histopathology
|
2010
|
0.84
|
|
8
|
Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22.
|
Genes Chromosomes Cancer
|
2008
|
0.82
|
|
9
|
Improved ultrastructural resolution by a new re-embedding procedure for formaldehyde-fixed paraffin-embedded tissues.
|
Histopathology
|
2009
|
0.82
|
|
10
|
COX-2 upregulation in thymomas and thymic carcinomas.
|
Int J Cancer
|
2006
|
0.81
|
|
11
|
A mathematical approach predicting the number of events in different tumors.
|
Pathol Oncol Res
|
2008
|
0.79
|
|
12
|
KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE).
|
Diagn Pathol
|
2014
|
0.78
|
|
13
|
Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
|
Hum Pathol
|
2008
|
0.78
|
|
14
|
Expression and mutational status of PDGFR in thymic tumours.
|
Anticancer Res
|
2009
|
0.75
|